BIAF bioAffinity Technologies
- 1.900
- +0.030+1.58%
bioAffinity Technologies News
10-Q: Quarterly report
BioAffinity Technologies Q1 EPS $(0.21) Down From $(0.18) YoY, Sales $2.41M Up From $921.00 YoY
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.21) per share. This is a 16.67 percent decrease over losses of $(0.18) per share from the same period last year. The company re
BioAffinity Technologies 1Q Loss/Shr 21c >BIAF
BioAffinity Technologies 1Q Loss/Shr 21c >BIAF
BioAffinity Technologies 1Q Loss $2.06M >BIAF
BioAffinity Technologies 1Q Loss $2.06M >BIAF
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M
09:17 AM EDT, 05/15/2024 (MT Newswires) -- Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M
BioAffinity Technologies News Update
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) shares recent Company news. CyPath Lung Sales Ramp Up Month over Month Sales of CyPath Lung, our noninvasive diagnostic test for the early detection
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BioAffinity Technologies Files to Sell 1.63M Shares for Holders
BioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company re
Press Release: BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results SAN ANTONIO--(BUSINESS WIRE)--April 01, 2024-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnol
BioAffinity Technologies 4Q Rev $2.2M >BIAF
BioAffinity Technologies 4Q Rev $2.2M >BIAF
BioAffinity (BIAF) Gains Traction In Pre-Market Trading: What's Driving The Momentum?
Recent trading session has witnessed a notable increase in the price of BioAffinity Technologies, Inc. (NASDAQ: BIAF), which has carried over into pre-market activity. Pre-hour trading saw the stock rise 6.40% to $2.16 after closing at $2.03 in the previous session with a significant 32.68% gain. In spite of the lack of instant news, the ...
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. Th
OCEA, RVSN and HOVR Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAptorum Gr (NASDAQ:APM) stock moved upwards by 780.6% to $12.77 during Wednesday's regular session. The company's market cap stands at $66.1 million. NKGen Biotech (NASDAQ:NKGN) stock rose 302.
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct...
BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers
BioAffinity Technologies Shares Resume Trade
BioAffinity Technologies Shares Resume Trade
Analysis
Price Target
No Data
